Assessment of Patients Treated With JETREA® for Vitreomacular Traction

Inclusion Criteria: * Diagnosis of vitreomacular traction/symptomatic vitreomacular adhesion (VMT/sVMA), with evidence of focal VMA visible on Spectral Domain Optical Coherence Tomography (SD-OCT). * Read, sign, and date an Institutional Review Board/Ethics Committee-approved informed consent form. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Women of childbearing potential if pregnant, breastfeeding, or not in agreement to use adequate birth control methods to prevent pregnancy throughout the study. * Hypersensitivity to ocriplasmin or any of the JETREA® excipients. * Active or suspected intraocular or periocular infection. * Presence of Epiretinal Membrane (ERM) over the macula at baseline. * Broad VMT/VMA \>1500 microns at baseline. * History of vitrectomy in the study eye. * History of laser photocoagulation to the macula in the study eye. * Any relevant concomitant ocular condition that, in the opinion of the investigator, could be expected to worsen or require surgical intervention during the study period. * Macular hole of \>400µm diameter in the study eye. * High myopia in the study eye. * Pseudo-exfoliation, Marfan's syndrome, phacodonesis or any other finding in the Investigator's opinion suggesting lens/zonular instability. * Aphakia. * History of retinal detachment. * Diabetic retinopathy, ischaemic retinopathies, retinal vein occlusions. * Recent ocular surgery or ocular injection. * Vitreous hemorrhage. * Exudative age-related …